Results from phase 3 YOSEMITE and RHINE trials on faricimab in DMO

Video
Conference|ASRS

Dr Caroline Baumal provides an overview of the efficacy, safety and durability of faricimab in diabetic macular oedema (DMO) at ASRS 2021.

Dr Caroline Baumal provides an overview of the efficacy, safety and durability of faricimab in diabetic macular oedema (DMO) at ASRS 2021. In her presentation, Dr Baumal highlights results from the Phase 3 YOSEMITE and RHINE trials.

The American Society of Retina Specialists (ASRS) is hosting its 39th Annual Scientific Meeting from 8-12 October 2021, at the JW Marriott San Antonio Hill Country Resort and Spa in San Antonio, Texas.

Related Content: Additional ASRS content | Retina | Inflammation & Infection

Recent Videos
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Quan Dong Nguyen, MD, MSc, of the Byers Eye Institute at Stanford University School of Medicine, discusses his presentation on Stargardt disease at the American Academy of Ophthalmology meeting
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
Related Content
A person in a business suit holds a lit-up lightbulb. Image credit: ©kamiphotos – stock.adobe.com

EssilorLuxottica announces agreement for acquisition of Espansione Group

Sydney M Crago
December 17th 2024
Article

Espansione Group's Light Modulation Low-level Light Therapy (LLLT) is used in ophthalmology and dermatology

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

A gloved hand holds two syringes full of fluid. Image credit: ©StudioLaMagica – stock.adobe.com

European Medicines Agency approves faricimab (Vabysmo) 6.0 mg single-dose prefilled syringe

Hattie Hayes
December 13th 2024
Article

The PFS is approved for treatment of neovascular age-related macular degeneration, diabetic macular oedema and macular oedema following retinal vein occlusion

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

Two charts which show Prevalence of Blindness and Moderate and Severe Visual Impairment Due to Diabetic Eye Complications (parts A and B)

Diabetic eye disease: Where are we now?

Tunde Peto, MD, PhD;Ali Erginay, MD
December 10th 2024
Article

Clinicians must consider redefining the metrics and intention behind functional outcomes, according to experts from the European Association for the Study of Diabetic Eye Complications

A stylist applies dye to a client's hair with a brush. Image credit: ©Taras Grebinets – stock.adobe.com

Case report: retinopathy associated with the use of hair dye aromatic amines

Lynda Charters
December 9th 2024
Article

Presentation closely resembled mitogen-activated extracellular signal-regulated kinase inhibitor–associated retinopathy

© 2024 MJH Life Sciences

All rights reserved.